Multisource Surveillance Study of Pregnancy and Infant Outcomes in Ocrelizumab-Exposed Women With Multiple Sclerosis (MELODIC Study) First published 28/02/2020 Last updated 02/07/2024 EU PAS number:EUPAS33879 Study Planned
RTI Health Solutions (RTI-HS) France Spain Sweden United Kingdom United Kingdom (Northern Ireland) United States First published:21/04/2010 Last updated 13/03/2025 Institution Not-for-profit ENCePP partner
Optum Germany First published:03/01/2012 Last updated 07/02/2014 Institution Outdated Other ENCePP partner
Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGY Denmark First published:20/07/2021 Last updated 02/04/2024 Institution Educational Institution ENCePP partner